Your browser doesn't support javascript.
loading
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.
Eng, Lawson; Azad, Abul Kalam; Qiu, Xin; Kong, Qin Quinn; Cheng, Dangxiao; Ying, Nanjiao; Tse, Alvina; Kuang, Qin; Dodbiba, Lorin; Renouf, Daniel J; Marsh, Sharon; Savas, Sevtap; Mackay, Helen J; Knox, Jennifer J; Darling, Gail E; Wong, Rebecca K S; Xu, Wei; Liu, Geoffrey; Faluyi, Olusola O.
Afiliação
  • Eng L; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Tor
  • Azad AK; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Qiu X; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Kong QQ; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Cheng D; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Ying N; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Institute of Biomedical Engineering, Hangzhou Dianzi University Xiasha, Hangzhou 310018, Zhejiang, P. R. China.
  • Tse A; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Kuang Q; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Dodbiba L; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Renouf DJ; British Columbia Cancer Agency, Department of Medical Oncology, University of British Columbia, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.
  • Marsh S; Faculty of Pharmacy and Pharmaceutical Sciences, 3142F, Katz Group Centre for Pharmacy & Health Research, University of Alberta, 11361-87 Ave, Edmonton, Alberta T6G 2E1, Canada.
  • Savas S; Discipline of Genetics, Faculty of Medicine, H4333C, Memorial University of Newfoundland, St. John's, Newfoundland A1B 3V6, Canada.
  • Mackay HJ; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Knox JJ; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
  • Darling GE; Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital, 200 Elizabeth Street, 9N-955, Toronto, Ontario M5G 2C4, Canada.
  • Wong RK; Department of Radiation Oncology, Princess Margaret Cancer Centre, 610 University Ave, Toronto, Ontario M5G 2M9, Canada and.
  • Xu W; Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Department of Biostatistics, Princess Margaret Cancer Centre, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Dalla
  • Liu G; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada, Division of Applied Molecular Oncology, Ontario Cancer Institute-Princess Margaret Cancer Centre and University of Tor
  • Faluyi OO; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.
Carcinogenesis ; 36(9): 956-62, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26014353
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Neovascularização Patológica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Receptor 2 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Neovascularização Patológica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article